T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas

Authors
Politi, Letterio S.
Brugnara, G.
Castellano, A.
Cadioli, M.
Altabella, L.
Peviani, M.
Mazzoleni, S.
Falini, A.
Galli, R.
UMass Chan Affiliations
Department of Radiology
Document Type
Response or Comment
Publication Date
2016-06-01
Keywords
Neoplasms
Neurology
Radiology

Metadata
Show full item record
Link to Full Text
https://doi.org/10.3174/ajnr.A4774
Abstract
We read with great interest the article by Arevalo-Perez et al, describing the potential value of T1-weighted dynamic contrast-enhanced MR imaging (DCE-MR imaging) as a biomarker for epidermal growth factor receptor variant III (EGFRvIII) mutation in patients with glioblastoma (GBM).
Source
AJNR Am J Neuroradiol. 2016 Jun;37(6):E49-51. Mar 17. Link to article on publisher's site
DOI
10.3174/ajnr.A4774
Permanent Link to this Item
http://hdl.handle.net/20.500.14038/48122
PubMed ID
26988813
Related Resources
Link to Article in PubMed
Collections